Know Cancer

forgot password

Phase 3, Randomized, Open Label Trial of Lenalidomide/Dexamethasone With or Without Elotuzumab in Relapsed or Refractory Multiple Myeloma (MM)

Phase 3
18 Years
Open (Enrolling)
Multiple Myeloma

Thank you

Trial Information

Phase 3, Randomized, Open Label Trial of Lenalidomide/Dexamethasone With or Without Elotuzumab in Relapsed or Refractory Multiple Myeloma (MM)

Inclusion Criteria:

- Documented progression from most recent line of therapy

- 1 - 3 prior lines of therapy

- Measurable disease

- Life expectancy ≥3 months

- Prior treatment with Lenalidomide permitted if:

1. Best response achieved was ≥ Partial Response (PR)

2. Patient was not refractory

3. Patient did not discontinue due to a Grade ≥ 3 related adverse event

4. Subject did not receive more than 9 cycles of Lenalidomide and had at least 9
months between the last dose of Lenalidomide and progression

Exclusion Criteria:

- Subjects with non-secretory or oligo-secretory or serum free light-chain only myeloma

- Active plasma cell leukemia

- Known Human immunodeficiency virus (HIV) infection or active hepatitis A, B, or C

Type of Study:


Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

Progression-free survival (PFS) - Time from randomization to date of first tumor progression or death due to any cause, provided death is not more than 10 weeks after the last tumor assessment

Outcome Time Frame:

Tumor assessments every 4 weeks (±1 week) relative to the first dose of study medication (median length of time for tumor assessments should be approximately 13 months)

Safety Issue:


Principal Investigator

Bristol-Myers Squibb

Investigator Role:

Study Director

Investigator Affiliation:

Bristol-Myers Squibb


Australia: Department of Health and Ageing Therapeutic Goods Administration

Study ID:




Start Date:

June 2011

Completion Date:

October 2017

Related Keywords:

  • Multiple Myeloma
  • Multiple Myeloma
  • Neoplasms, Plasma Cell



University of Iowa Hospitals and Clinics Iowa City, Iowa  52242
Washington University School of Medicine Saint Louis, Missouri  63110
Dana-Farber Cancer Institute Boston, Massachusetts  02115
Capitol Comprehensive Cancer Care Clinic Jefferson City, Missouri  65109
Mount Sinai Comprehensive Cancer Center Miami Beach, Florida  33140
Alta Bates Summit Comprehensive Cancer Center Berkeley, California  94704
Mid Dakota Clinic, PC Bismarck, North Dakota  58501
Palm Beach Cancer Institute West Palm Beach, Florida  33401
Tennessee Cancer Specialists Knoxville, Tennessee  37920
Medical Oncology Care Associates Orange, California  92668
Henry Ford Health System Detroit, Michigan  48202
Local Institution Bronx, New York  
Local Institution Vancouver, Washington  
Local Institution Green Bay, Wisconsin  
ACRC/Arizona Clinical Research Center, Inc. Tucson, Arizona  85712
Local Institution Birmingham, Alabama  
Local Institution Springfield, Massachusetts  
Local Institution Oklahoma City, Oklahoma  
Local Institution North Charleston, South Carolina  
Local Institution Austin, Texas  
Cancer Specialists of South Texas, PA Corpus Christi, Texas  78412
Sharp Clinical Oncology Research San Diego, California  92123
St. Luke's-Roosevelt Hospital Center New York, New York  
Local Institution Louisville, Kentucky  
Winship Cancer Institute, Emory University Atlanta, Georgia  30322
Local Institution Detroit, Michigan  
Investigative Clinical Research of Indiana, LLC Indianapolis, Indiana  46254
Northwest Alabama Cancer Center, PC Florence, Alabama  35630
NYU Clinical Cancer Center New York, New York  10016
Pasco Hernando Oncology Associates, PA New Port Richey, Florida  34642
Northwest Cancer Center Houston, Texas  77042
Weill Cornell Medical College New York, New York  10021
Mecklenburg Medical Group Charlotte, North Carolina  
University of Texas Southwestern Dallas, Texas  75390
Charleston Hematology Oncology Associates, PA Charleston, South Carolina  29403
Gaston Hematology & Oncology Gastonia, North Carolina  28054
Compassionate Cancer Care Medical Group Inc Fountain Valley, California  92708
Cancer Institute Of Florida Orlando, Florida  32804
St Johns Medical Research Institute, Inc. Springfield, Missouri  65807
San Diego Pacific Oncology& Hematology Associates, Inc Encinitas, California  92024
Marin Cancer Care, Inc Greenbrae, California  94904
Space Coastal Medical Assoc. Titusville, Florida  32796
Cancer Center Of Acadiana At Lafayette General Lafayette, Louisiana  70503
Willis Knighton Cancer Center Shreveport, Louisiana  71103
Univ Of Oklahoma Health Science Center Oklahoma City, Oklahoma  73104
Hematology-Oncology Associates Of Fredricksburg, Inc Fredricksburg, Virginia  22408